Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	galactosylceramidase activity	GALC LCT GBA2 GBA3	3.39e-08	5	183	4	GO:0004336
GeneOntologyMolecularFunction	beta-glucosidase activity	LCT GBA2 GBA3 KL	1.01e-07	6	183	4	GO:0008422
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	GALC MANBA LCT GBA2 GBA3 KL OTOGL EDEM2 HYAL2	4.48e-07	103	183	9	GO:0004553
GeneOntologyMolecularFunction	apyrase activity	ENTPD1 ENTPD3 ENTPD8	7.57e-07	3	183	3	GO:0004050
GeneOntologyMolecularFunction	glucosylceramidase activity	LCT GBA2 GBA3	3.01e-06	4	183	3	GO:0004348
GeneOntologyMolecularFunction	carbohydrate binding	P4HA2 CRYBG2 MANBA ACR ADGRL1 BCAN PKD1L2 PGD PKD1 CRYBG1 C4A C4B ZG16	6.00e-06	310	183	13	GO:0030246
GeneOntologyMolecularFunction	hydrolase activity, acting on glycosyl bonds	GALC MANBA LCT GBA2 GBA3 KL OTOGL EDEM2 HYAL2	7.36e-06	144	183	9	GO:0016798
GeneOntologyMolecularFunction	glucosidase activity	LCT GBA2 GBA3 KL	8.61e-06	15	183	4	GO:0015926
GeneOntologyMolecularFunction	UDP phosphatase activity	ENTPD1 ENTPD3 ENTPD8	6.11e-05	9	183	3	GO:0045134
GeneOntologyMolecularFunction	opsonin binding	ITGAM CFHR4 C4A C4B	7.43e-05	25	183	4	GO:0001846
GeneOntologyMolecularFunction	glycosylceramidase activity	LCT GBA3	8.35e-05	2	183	2	GO:0017042
GeneOntologyMolecularFunction	phosphoenolpyruvate carboxykinase activity	PCK1 PCK2	8.35e-05	2	183	2	GO:0004611
GeneOntologyMolecularFunction	phosphoenolpyruvate carboxykinase (GTP) activity	PCK1 PCK2	8.35e-05	2	183	2	GO:0004613
GeneOntologyMolecularFunction	GDP phosphatase activity	ENTPD1 ENTPD3 ENTPD8	1.57e-04	12	183	3	GO:0004382
GeneOntologyMolecularFunction	complement binding	ITGAM CFHR4 C4A C4B	2.01e-04	32	183	4	GO:0001848
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	TRPM6 TRPM4 SLC5A10 PKD1L1 SLC5A7 PKD1L2 RYR2 TFRC SLC6A9 SLC6A13 PKD1 SLC5A8 KCNK17	3.72e-04	465	183	13	GO:0046873
GeneOntologyMolecularFunction	symporter activity	SLC5A10 SLC5A7 SLC45A4 SLC6A9 SLC6A13 SLC16A14 SLC5A8	4.74e-04	150	183	7	GO:0015293
GeneOntologyMolecularFunction	N-acetylmuramoyl-L-alanine amidase activity	PGLYRP4 PGLYRP1	4.95e-04	4	183	2	GO:0008745
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	GABRB1 TRPM6 GABRD SLC37A1 TRPM4 SLC5A10 PKD1L1 SLC5A7 PKD1L2 RYR2 SLC45A4 TFRC SLC6A9 SLC6A13 PKD1 SLC5A8 KCNK17	6.26e-04	758	183	17	GO:0015318
GeneOntologyMolecularFunction	peptidoglycan binding	PGLYRP4 PGLYRP1 ZG16	6.59e-04	19	183	3	GO:0042834
GeneOntologyMolecularFunction	nucleoside diphosphate phosphatase activity	ENTPD1 ENTPD3 ENTPD8	7.70e-04	20	183	3	GO:0017110
GeneOntologyMolecularFunction	solute:monoatomic cation symporter activity	SLC5A10 SLC5A7 SLC45A4 SLC6A9 SLC6A13 SLC5A8	8.05e-04	119	183	6	GO:0015294
GeneOntologyMolecularFunction	peptidoglycan immune receptor activity	PGLYRP4 PGLYRP1	8.20e-04	5	183	2	GO:0016019
GeneOntologyMolecularFunction	solute:sodium symporter activity	SLC5A10 SLC5A7 SLC6A9 SLC6A13 SLC5A8	8.93e-04	81	183	5	GO:0015370
GeneOntologyMolecularFunction	phosphotyrosine residue binding	SOCS3 CBLC CBL PIK3R1	1.22e-03	51	183	4	GO:0001784
GeneOntologyMolecularFunction	calcium channel activity	TRPM6 TRPM4 PKD1L1 PKD1L2 RYR2 PKD1	1.22e-03	129	183	6	GO:0005262
GeneOntologyMolecularFunction	NAD+-protein-arginine ADP-ribosyltransferase activity	ARF4 ART5	1.70e-03	7	183	2	GO:0106274
GeneOntologyMolecularFunction	ankyrin repeat binding	SHANK1 TNKS1BP1	1.70e-03	7	183	2	GO:0071532
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	TRPM6 TRPM4 SLC5A10 PKD1L1 SLC5A7 PKD1L2 RYR2 SLC45A4 TFRC SLC6A9 SLC6A13 PKD1 SLC5A8 KCNK17	1.97e-03	627	183	14	GO:0022890
GeneOntologyMolecularFunction	aspartic endopeptidase activity, intramembrane cleaving	SPPL2A SPPL2C	2.26e-03	8	183	2	GO:0042500
GeneOntologyMolecularFunction	protein tyrosine kinase inhibitor activity	SOCS3 HYAL2	2.26e-03	8	183	2	GO:0030292
GeneOntologyMolecularFunction	hyaluronic acid binding	BCAN ITIH4 HYAL2	2.32e-03	29	183	3	GO:0005540
GeneOntologyBiologicalProcess	glycosylceramide catabolic process	GALC LCT GBA2 GBA3	2.75e-06	12	182	4	GO:0046477
GeneOntologyBiologicalProcess	glycosylceramide metabolic process	GALC LCT GBA2 GBA3	3.79e-05	22	182	4	GO:0006677
GeneOntologyBiologicalProcess	glycosphingolipid catabolic process	GALC LCT GBA2 GBA3	5.43e-05	24	182	4	GO:0046479
GeneOntologyBiologicalProcess	ceramide catabolic process	GALC LCT GBA2 GBA3	7.53e-05	26	182	4	GO:0046514
GeneOntologyBiologicalProcess	propionate catabolic process	PCK1 PCK2	7.74e-05	2	182	2	GO:0019543
GeneOntologyBiologicalProcess	glycerol biosynthetic process from pyruvate	PCK1 PCK2	7.74e-05	2	182	2	GO:0046327
GeneOntologyBiologicalProcess	glycolipid catabolic process	GALC LCT GBA2 GBA3	8.78e-05	27	182	4	GO:0019377
GeneOntologyCellularComponent	side of membrane	ICOSLG ITGA11 SOCS3 BCAN ITGA2B LCT ITGAE ITGAM CD163 RYR2 CFHR4 TFRC CD1D SPPL2A NPTXR CD163L1 ENTPD1 GLIPR1L1 CD200R1L ALG6 SPPL2C HYAL2	1.36e-05	875	188	22	GO:0098552
GeneOntologyCellularComponent	symbiont cell surface	CFHR4 C4A C4B	3.88e-05	8	188	3	GO:0106139
GeneOntologyCellularComponent	other organism part	CFHR4 C4A C4B	5.78e-05	9	188	3	GO:0044217
GeneOntologyCellularComponent	integrin complex	ITGA11 ITGA2B ITGAE ITGAM	1.87e-04	32	188	4	GO:0008305
GeneOntologyCellularComponent	protein complex involved in cell adhesion	ITGA11 ITGA2B ITGAE ITGAM GLIPR1L1	1.88e-04	59	188	5	GO:0098636
GeneOntologyCellularComponent	external side of plasma membrane	ICOSLG ITGA11 ITGA2B LCT ITGAE ITGAM CD163 CFHR4 TFRC CD1D CD163L1 ENTPD1 CD200R1L HYAL2	2.65e-04	519	188	14	GO:0009897
GeneOntologyCellularComponent	somatodendritic compartment	GABRB1 CHL1 SHANK1 GABRD CNTNAP3B TRPM4 SRD5A2 RAPGEF4 CNTNAP3 SLC5A7 BACE1 BCAN GRM8 ARF4 CFHR4 DIP2A HMCN2 NPTXR ASL ENTPD1 C4A C4B C9orf72 KLHL17	2.84e-04	1228	188	24	GO:0036477
GeneOntologyCellularComponent	axon	GABRD CNTNAP3B FKBP15 MYO9A RAPGEF4 INSRR CNTNAP3 SLC5A7 BACE1 ADGRL1 BCAN CBL CFHR4 HMCN2 NPTXR C4A C4B C9orf72 DYNC1I1	4.46e-04	891	188	19	GO:0030424
GeneOntologyCellularComponent	neuronal cell body	GABRD CNTNAP3B TRPM4 SRD5A2 RAPGEF4 CNTNAP3 SLC5A7 BACE1 GRM8 CFHR4 HMCN2 NPTXR ASL ENTPD1 C4A C4B C9orf72 KLHL17	5.57e-04	835	188	18	GO:0043025
GeneOntologyCellularComponent	Golgi-associated vesicle	ACR BACE1 SPPL2A AP1G1 PKD1 SPPL2C	5.83e-04	114	188	6	GO:0005798
GeneOntologyCellularComponent	cell body	GABRD CNTNAP3B TRPM4 SRD5A2 RAPGEF4 CNTNAP3 SLC5A7 BACE1 CCT7 GRM8 CFHR4 HMCN2 NPTXR ASL ENTPD1 C4A C4B C9orf72 KLHL17	7.38e-04	929	188	19	GO:0044297
GeneOntologyCellularComponent	3M complex	OBSL1 FBXW8	7.90e-04	5	188	2	GO:1990393
Domain	WD_REPEATS_1	WDR64 WDR5B DYNC2I2 COP1 PIK3R4 FBXW8 NWD2 GTF3C2 CDC40 TULP4 KCTD3 TLE6 IFT80 CFAP57 HERC2 HERC1 DYNC1I1 RIC1 TBL1X SEC13	4.51e-12	278	184	20	PS00678
Domain	WD_REPEATS_2	WDR64 WDR5B DYNC2I2 COP1 PIK3R4 FBXW8 NWD2 GTF3C2 CDC40 TULP4 KCTD3 TLE6 IFT80 CFAP57 HERC2 HERC1 DYNC1I1 RIC1 TBL1X SEC13	4.82e-12	279	184	20	PS50082
Domain	WD_REPEATS_REGION	WDR64 WDR5B DYNC2I2 COP1 PIK3R4 FBXW8 NWD2 GTF3C2 CDC40 TULP4 KCTD3 TLE6 IFT80 CFAP57 HERC2 HERC1 DYNC1I1 RIC1 TBL1X SEC13	4.82e-12	279	184	20	PS50294
Domain	WD40_repeat_dom	WDR64 WDR5B DYNC2I2 COP1 LRRK1 PIK3R4 FBXW8 NWD2 GTF3C2 CDC40 TULP4 KCTD3 TLE6 IFT80 CFAP57 HERC1 DYNC1I1 RIC1 TBL1X SEC13	1.51e-11	297	184	20	IPR017986
Domain	WD40_repeat	WDR64 WDR5B DYNC2I2 COP1 PIK3R4 FBXW8 NWD2 GTF3C2 CDC40 TULP4 KCTD3 TLE6 IFT80 CFAP57 HERC2 HERC1 DYNC1I1 TBL1X SEC13	2.66e-11	272	184	19	IPR001680
Domain	WD40	WDR64 WDR5B DYNC2I2 COP1 PIK3R4 FBXW8 NWD2 GTF3C2 CDC40 TULP4 KCTD3 TLE6 IFT80 CFAP57 HERC1 DYNC1I1 TBL1X SEC13	1.73e-10	268	184	18	SM00320
Domain	-	WDR64 WDR5B DYNC2I2 COP1 PIK3R4 FBXW8 NWD2 GTF3C2 CDC40 TULP4 KCTD3 TLE6 IFT80 CFAP57 HERC1 DYNC1I1 RIC1 TBL1X SEC13	8.34e-10	333	184	19	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	WDR64 WDR5B DYNC2I2 COP1 PIK3R4 FBXW8 NWD2 GTF3C2 CDC40 TULP4 KCTD3 TLE6 IFT80 CFAP57 HERC1 DYNC1I1 RIC1 TBL1X SEC13	9.22e-10	335	184	19	IPR015943
Domain	WD40	WDR64 WDR5B DYNC2I2 COP1 PIK3R4 FBXW8 GTF3C2 CDC40 TULP4 TLE6 IFT80 CFAP57 HERC1 DYNC1I1 TBL1X SEC13	6.23e-09	259	184	16	PF00400
Domain	Glyco_hydro_1_N_CS	LCT GBA3 KL	3.74e-06	4	184	3	IPR033132
Domain	Glyco_hydro_1_AS	LCT GBA3 KL	3.74e-06	4	184	3	IPR018120
Domain	REJ	PKD1L1 PKD1L2 PKD1	3.74e-06	4	184	3	PS51111
Domain	REJ_dom	PKD1L1 PKD1L2 PKD1	3.74e-06	4	184	3	IPR014010
Domain	WD40_repeat_CS	WDR5B COP1 PIK3R4 FBXW8 NWD2 GTF3C2 CDC40 KCTD3 HERC1 TBL1X	5.34e-06	164	184	10	IPR019775
Domain	GLYCOSYL_HYDROL_F1_1	LCT GBA3 KL	9.27e-06	5	184	3	PS00572
Domain	Glyco_hydro_1	LCT GBA3 KL	9.27e-06	5	184	3	PF00232
Domain	GLYCOSYL_HYDROL_F1_2	LCT GBA3 KL	9.27e-06	5	184	3	PS00653
Domain	Glyco_hydro_1	LCT GBA3 KL	9.27e-06	5	184	3	IPR001360
Domain	Glycoside_hydrolase_SF	GALC MANBA LCT GBA3 KL HYAL2	1.32e-05	53	184	6	IPR017853
Domain	PKD/REJ-like	PKD1L1 PKD1L2 PKD1	1.84e-05	6	184	3	IPR002859
Domain	REJ	PKD1L1 PKD1L2 PKD1	1.84e-05	6	184	3	PF02010
Domain	-	GALC MANBA LCT GBA3 KL	2.24e-05	35	184	5	3.20.20.80
Domain	Integrin_alpha-2	ITGA11 ITGA2B ITGAE ITGAM	2.50e-05	18	184	4	IPR013649
Domain	LH2	PKD1L1 PKD1L2 LOXHD1 PKD1	2.50e-05	18	184	4	SM00308
Domain	INTEGRIN_ALPHA	ITGA11 ITGA2B ITGAE ITGAM	2.50e-05	18	184	4	PS00242
Domain	Integrin_alpha2	ITGA11 ITGA2B ITGAE ITGAM	2.50e-05	18	184	4	PF08441
Domain	Integrin_alpha	ITGA11 ITGA2B ITGAE ITGAM	2.50e-05	18	184	4	IPR000413
Domain	Int_alpha	ITGA11 ITGA2B ITGAE ITGAM	3.15e-05	19	184	4	SM00191
Domain	Int_alpha_beta-p	ITGA11 ITGA2B ITGAE ITGAM	3.15e-05	19	184	4	IPR013519
Domain	Glyco_hydro_catalytic_dom	GALC MANBA LCT GBA3 KL	3.39e-05	38	184	5	IPR013781
Domain	RCC1	HERC2 HERC1 HERC4 HERC5	3.90e-05	20	184	4	PF00415
Domain	-	PKD1L1 PKD1L2 LOXHD1 PKD1	4.79e-05	21	184	4	2.60.60.20
Domain	PLAT	PKD1L1 PKD1L2 LOXHD1 PKD1	4.79e-05	21	184	4	PF01477
Domain	PLAT/LH2_dom	PKD1L1 PKD1L2 LOXHD1 PKD1	4.79e-05	21	184	4	IPR001024
Domain	PLAT	PKD1L1 PKD1L2 LOXHD1 PKD1	4.79e-05	21	184	4	PS50095
Domain	RCC1_1	HERC2 HERC1 HERC4 HERC5	4.79e-05	21	184	4	PS00625
Domain	RCC1_2	HERC2 HERC1 HERC4 HERC5	4.79e-05	21	184	4	PS00626
Domain	RCC1_3	HERC2 HERC1 HERC4 HERC5	4.79e-05	21	184	4	PS50012
Domain	GDA1_CD39_NTPase	ENTPD1 ENTPD3 ENTPD8	5.08e-05	8	184	3	IPR000407
Domain	GDA1_CD39	ENTPD1 ENTPD3 ENTPD8	5.08e-05	8	184	3	PF01150
Domain	GDA1_CD39_NTPASE	ENTPD1 ENTPD3 ENTPD8	5.08e-05	8	184	3	PS01238
Domain	-	HERC2 HERC1 HERC4 HERC5	5.80e-05	22	184	4	2.130.10.30
Domain	FG_GAP	ITGA11 ITGA2B ITGAE ITGAM	5.80e-05	22	184	4	PS51470
Domain	Reg_chr_condens	HERC2 HERC1 HERC4 HERC5	5.80e-05	22	184	4	IPR000408
Domain	RCC1/BLIP-II	HERC2 HERC1 HERC4 HERC5	6.97e-05	23	184	4	IPR009091
Domain	FG-GAP	ITGA11 ITGA2B ITGAE ITGAM	8.30e-05	24	184	4	PF01839
Domain	FG-GAP	ITGA11 ITGA2B ITGAE ITGAM	8.30e-05	24	184	4	IPR013517
Domain	PEP_carboxykin_GTP_CS	PCK1 PCK2	9.65e-05	2	184	2	IPR018091
Domain	PEPCK	PCK1 PCK2	9.65e-05	2	184	2	PF00821
Domain	PEP_carboxykinase_GTP	PCK1 PCK2	9.65e-05	2	184	2	IPR008209
Domain	PEPCK_GTP	PCK1 PCK2	9.65e-05	2	184	2	PS00505
Domain	PEP_carboxykinase_N	PCK1 PCK2	9.65e-05	2	184	2	IPR008210
Domain	PEP_carboxykinase_C	PCK1 PCK2	9.65e-05	2	184	2	IPR013035
Domain	-	PCK1 PCK2	9.65e-05	2	184	2	3.90.228.20
Domain	-	PCK1 PCK2	9.65e-05	2	184	2	3.40.449.10
Domain	Integrin_dom	ITGA11 ITGA2B ITGAE ITGAM	9.81e-05	25	184	4	IPR032695
Domain	HECT	HERC2 HERC1 HERC4 HERC5	1.34e-04	27	184	4	PF00632
Domain	HECTc	HERC2 HERC1 HERC4 HERC5	1.34e-04	27	184	4	SM00119
Domain	HECT_dom	HERC2 HERC1 HERC4 HERC5	1.34e-04	27	184	4	IPR000569
Domain	HECT	HERC2 HERC1 HERC4 HERC5	1.34e-04	27	184	4	PS50237
Domain	Integrin_alpha	ITGA2B ITGAE ITGAM	1.46e-04	11	184	3	PF00357
Domain	PKD_channel	PKD1L1 PKD1L2 PKD1	1.46e-04	11	184	3	PF08016
Domain	PKD1_2_channel	PKD1L1 PKD1L2 PKD1	1.46e-04	11	184	3	IPR013122
Domain	VWFA	ITGA11 COL20A1 ITGAE ITGAM ITIH4 HMCN2	1.59e-04	82	184	6	PS50234
Domain	VWA	ITGA11 COL20A1 ITGAE ITGAM ITIH4 HMCN2	1.81e-04	84	184	6	SM00327
Domain	SSF	SLC5A10 SLC5A7 SLC5A8	1.94e-04	12	184	3	PF00474
Domain	NA_SOLUT_SYMP_2	SLC5A10 SLC5A7 SLC5A8	1.94e-04	12	184	3	PS00457
Domain	Na/solute_symporter	SLC5A10 SLC5A7 SLC5A8	1.94e-04	12	184	3	IPR001734
Domain	NA_SOLUT_SYMP_3	SLC5A10 SLC5A7 SLC5A8	1.94e-04	12	184	3	PS50283
Domain	VWA	ITGA11 COL20A1 ITGAE ITGAM ITIH4	2.23e-04	56	184	5	PF00092
Domain	Adaptor_Cbl_EF_hand-like	CBLC CBL	2.88e-04	3	184	2	IPR014741
Domain	Adaptor_Cbl_SH2-like	CBLC CBL	2.88e-04	3	184	2	IPR014742
Domain	Adaptor_Cbl	CBLC CBL	2.88e-04	3	184	2	IPR024162
Domain	Cbl_PTB	CBLC CBL	2.88e-04	3	184	2	IPR024159
Domain	Cbl_N2	CBLC CBL	2.88e-04	3	184	2	PF02761
Domain	Cbl_N3	CBLC CBL	2.88e-04	3	184	2	PF02762
Domain	Cbl_N	CBLC CBL	2.88e-04	3	184	2	PF02262
Domain	Adaptor_Cbl_N_hlx	CBLC CBL	2.88e-04	3	184	2	IPR003153
Domain	CBL_PTB	CBLC CBL	2.88e-04	3	184	2	PS51506
Domain	-	CBLC CBL	2.88e-04	3	184	2	1.20.930.20
Domain	GPS	PKD1L1 ADGRL1 PKD1L2 PKD1	4.20e-04	36	184	4	PS50221
Domain	VWF_A	ITGA11 COL20A1 ITGAE ITGAM ITIH4 HMCN2	4.42e-04	99	184	6	IPR002035
Domain	GPS	PKD1L1 ADGRL1 PKD1L2 PKD1	4.67e-04	37	184	4	IPR000203
Domain	Integrin_alpha_C_CS	ITGA2B ITGAE ITGAM	4.79e-04	16	184	3	IPR018184
Domain	Amidase_domain	PGLYRP4 PGLYRP1	5.72e-04	4	184	2	IPR002502
Domain	PGRP	PGLYRP4 PGLYRP1	5.72e-04	4	184	2	SM00701
Domain	Amidase_2	PGLYRP4 PGLYRP1	5.72e-04	4	184	2	PF01510
Domain	Ami_2	PGLYRP4 PGLYRP1	5.72e-04	4	184	2	SM00644
Domain	-	PGLYRP4 PGLYRP1	5.72e-04	4	184	2	3.40.80.10
Domain	PGRP_domain_met/bac	PGLYRP4 PGLYRP1	5.72e-04	4	184	2	IPR006619
Domain	PGRP	PGLYRP4 PGLYRP1	5.72e-04	4	184	2	IPR015510
Domain	PA	TFRC SPPL2A SPPL2C	8.11e-04	19	184	3	PF02225
Domain	PA_domain	TFRC SPPL2A SPPL2C	8.11e-04	19	184	3	IPR003137
Domain	Anaphylatoxin_comp_syst	C4A C4B	9.47e-04	5	184	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	9.47e-04	5	184	2	IPR001840
Domain	Peptidase_A22B_SPP	SPPL2A SPPL2C	9.47e-04	5	184	2	IPR007369
Domain	Gal_Lectin	ADGRL1 PKD1L2	9.47e-04	5	184	2	PF02140
Domain	Lectin_gal-bd_dom	ADGRL1 PKD1L2	9.47e-04	5	184	2	IPR000922
Domain	SUEL_LECTIN	ADGRL1 PKD1L2	9.47e-04	5	184	2	PS50228
Domain	DMAP_binding	DIP2A DIP2C	9.47e-04	5	184	2	PF06464
Pathway	REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS	ENTPD1 ENTPD3 ENTPD8	4.96e-05	8	138	3	M27737
Pathway	REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS	ENTPD1 ENTPD3 ENTPD8	4.96e-05	8	138	3	MM15486
Pathway	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	SOCS3 COP1 CBLC CBL FBXW8 HERC2 HERC1 HERC4	5.37e-05	135	138	8	M15247
Pathway	PID_INTEGRIN_CS_PATHWAY	ITGA11 ITGA2B ITGAE ITGAM	1.11e-04	26	138	4	M47
Pathway	REACTOME_GLUCONEOGENESIS	SLC37A1 GAPDH PCK1 PCK2	1.11e-04	26	138	4	M13748
Pathway	REACTOME_GLUCONEOGENESIS	SLC37A1 GAPDH PCK1 PCK2	1.11e-04	26	138	4	MM15392
Pubmed	Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8.	ENTPD1 ENTPD3 ENTPD8	6.29e-07	4	189	3	18404504
Pubmed	Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists.	ENTPD1 ENTPD3 ENTPD8	6.29e-07	4	189	3	17727821
Pubmed	A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea.	TRPM6 TRPM4 PKD1L1 PKD1L2 PKD1	9.43e-07	33	189	5	19834762
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SHANK1 RALGAPA1 GAPDH MYO9A ACO2 RAPGEF4 ADGRL1 CCT7 BCAN ARF4 ARF5 PIK3R4 DIP2A NWD2 AP1G1 SCAMP5 TRAPPC10 C4A TNKS1BP1 C4B DYNC1I1 ALDH7A1 SEC13 KPNA3	1.03e-06	1431	189	24	37142655
Pubmed	A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis.	ITGAM C4A C4B	1.57e-06	5	189	3	9382884
Pubmed	The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects.	HERC1 HERC4 HERC5	1.57e-06	5	189	3	15676274
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRPM4 CRYBG2 RAPGEF6 SOCS3 KDM3B IPP CBLC ADGRL1 LRRK1 GBA2 LPIN3 DIP2A TULP4 PKD1 DIP2C TNKS1BP1 HERC2 HERC1 RIC1 KLHL17	2.84e-06	1105	189	20	35748872
Pubmed	Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation.	CBLC CBL PIK3R4 PIK3R1	3.07e-06	19	189	4	31959764
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ZNF609 RAPGEF6 OBSL1 KDM3B PIK3R4 LPIN3 DIP2A CDC40 AP1G1 TSR1 TLL1 BUB1B C4A C4B RIC1	3.07e-06	650	189	15	38777146
Pubmed	Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H.	CFHR4 C4A C4B	3.12e-06	6	189	3	16849499
Pubmed	cbl-b inhibits epidermal growth factor receptor signaling.	CBLC CBL PIK3R1	3.12e-06	6	189	3	10086340
Pubmed	Spatiotemporal Analysis of a Glycolytic Activity Gradient Linked to Mouse Embryo Mesoderm Development.	GAPDH ACO2 LCT PGD PCK1 PCK2 ALDH7A1	3.16e-06	114	189	7	28245920
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	POLR2B RAPGEF4 TGM5 PIK3R4 DIP2A LOXHD1 PTPRB GRID2IP HPR C4A C4B HERC1 RIC1	3.75e-06	497	189	13	36774506
Pubmed	Developmental waves of mechanosensitivity acquisition in sensory neuron subtypes during embryonic development.	TRPM6 TRPM4 PKD1L1 PKD1L2 PKD1	4.11e-06	44	189	5	19322198
Pubmed	Systematic protein-protein interaction mapping for clinically relevant human GPCRs.	GABRD SLC37A1 TRPM4 NPTX1 CENPB GAPDH ACO2 OBSL1 BACE1 TCTA SLC45A4 TRAP1 PKD1 HERC2 SEC13	7.10e-06	697	189	15	28298427
Pubmed	C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens.	ITGAM C4A C4B	8.67e-06	8	189	3	24474777
Pubmed	Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice.	LRRK1 TG DUOX1 KL	1.15e-05	26	189	4	33905568
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	FKBP15 P4HA2 ZNF609 GALC DYNC2I2 CENPB OBSL1 DGKE RABL3 LPIN3 ACSL3 TRAP1 NPHP3 GTF3C2 PIK3R1 KCTD3 TRAPPC10 TNKS1BP1 IFT80 PCK2 KPNA3	1.16e-05	1321	189	21	27173435
Pubmed	TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.	GAPDH CBL PIK3R1	1.30e-05	9	189	3	15107835
Pubmed	Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.	ITGA11 ITGA2B ITGAE ITGAM	1.34e-05	27	189	4	31541017
Pubmed	Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells.	PKD1L1 PKD1L2 PKD1	1.84e-05	10	189	3	16805797
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	CHL1 ICOSLG SLC5A10 PGLYRP1 GAPDH ITGAM PGD PLBD2 ITIH4 ARF5 KL SPPL2A HPR C4A C4B LRRN4 SLC5A8 ALDH7A1	2.42e-05	1070	189	18	23533145
Pubmed	Confirmation of genomewide association signals in Chinese Han population reveals risk loci for ischemic stroke.	BCAN CRYBG1 KCNK17	2.52e-05	11	189	3	19910543
Pubmed	Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.	CFHR4 C4A C4B	2.52e-05	11	189	3	23204401
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	RALGAPA1 NPTX1 DYNC2I2 MYO9A ADGRL1 DGKE ACSL3 NWD2 KCTD3 TRAPPC10 HERC2	2.60e-05	430	189	11	32581705
Pubmed	Polycystin-1L2 is a novel G-protein-binding protein.	PKD1L1 PKD1L2	2.94e-05	2	189	2	15203210
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	2.94e-05	2	189	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	2.94e-05	2	189	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	2.94e-05	2	189	2	15998580
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	2.94e-05	2	189	2	19062096
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	2.94e-05	2	189	2	19933335
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	2.94e-05	2	189	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	2.94e-05	2	189	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	2.94e-05	2	189	2	12207352
Pubmed	Cloning, genomic organization and expression pattern of a novel Drosophila gene, the disco-interacting protein 2 (dip2), and its murine homolog.	DIP2A DIP2C	2.94e-05	2	189	2	12137943
Pubmed	CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.	CBLC CBL	2.94e-05	2	189	2	22315494
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	2.94e-05	2	189	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	2.94e-05	2	189	2	22387014
Pubmed	CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene.	CBL PIK3R1	2.94e-05	2	189	2	8695807
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	2.94e-05	2	189	2	23749435
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	2.94e-05	2	189	2	23918728
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	2.94e-05	2	189	2	3037333
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	2.94e-05	2	189	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	2.94e-05	2	189	2	4216347
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	2.94e-05	2	189	2	6950384
Pubmed	Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis.	PCK1 PCK2	2.94e-05	2	189	2	38697449
Pubmed	Mouse CD11bhigh lung dendritic cells have more potent capability to induce IgA than CD103+ lung dendritic cells in vitro.	ITGAE ITGAM	2.94e-05	2	189	2	22268142
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	2.94e-05	2	189	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	2.94e-05	2	189	2	8428773
Pubmed	Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans.	LCT GBA3	2.94e-05	2	189	2	12594539
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	2.94e-05	2	189	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	2.94e-05	2	189	2	21345967
Pubmed	Role of phosphoinositide 3-kinase and the Cbl adaptor protein in coupling the alpha4beta1 integrin to mitogen-activated protein kinase signalling.	CBL PIK3R1	2.94e-05	2	189	2	10620516
Pubmed	Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis.	CD163 CD163L1	2.94e-05	2	189	2	11124526
Pubmed	c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway.	CBL PIK3R1	2.94e-05	2	189	2	9414268
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	2.94e-05	2	189	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	2.94e-05	2	189	2	2302180
Pubmed	Deregulated expression of a longevity gene, Klotho, in the C9orf72 deletion mice with impaired synaptic plasticity and adult hippocampal neurogenesis.	KL C9orf72	2.94e-05	2	189	2	32887666
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	2.94e-05	2	189	2	26807827
Pubmed	Association of a polymorphism in the gene encoding phosphoenolpyruvate carboxykinase 1 with high-density lipoprotein and triglyceride levels.	PCK1 PCK2	2.94e-05	2	189	2	16132948
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	2.94e-05	2	189	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	2.94e-05	2	189	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	2.94e-05	2	189	2	29080553
Pubmed	Ras-dependent, Ca2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells.	CBL PIK3R1	2.94e-05	2	189	2	8995243
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	2.94e-05	2	189	2	6589636
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	2.94e-05	2	189	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	2.94e-05	2	189	2	17728371
Pubmed	Structure and organization of the C4 genes.	C4A C4B	2.94e-05	2	189	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	2.94e-05	2	189	2	6149581
Pubmed	The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.	C4A C4B	2.94e-05	2	189	2	12115608
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	2.94e-05	2	189	2	3542363
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	2.94e-05	2	189	2	2387317
Pubmed	Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.	C4A C4B	2.94e-05	2	189	2	16908004
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	2.94e-05	2	189	2	7365238
Pubmed	Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.	C4A C4B	2.94e-05	2	189	2	7391573
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	2.94e-05	2	189	2	17971360
Pubmed	Clinical features of patients with homozygous complement C4A or C4B deficiency.	C4A C4B	2.94e-05	2	189	2	29928053
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	2.94e-05	2	189	2	17971229
Pubmed	Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.	C4A C4B	2.94e-05	2	189	2	6881182
Pubmed	Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt.	CBL PIK3R1	2.94e-05	2	189	2	10918571
Pubmed	The protein product of the proto-oncogene c-cbl forms a complex with phosphatidylinositol 3-kinase p85 and CD19 in anti-IgM-stimulated human B-lymphoma cells.	CBL PIK3R1	2.94e-05	2	189	2	8896416
Pubmed	Partial C4 deficiency in juvenile idiopathic arthritis patients.	C4A C4B	2.94e-05	2	189	2	17921792
Pubmed	Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.	C4A C4B	2.94e-05	2	189	2	21880985
Pubmed	Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.	ITGAE ENTPD1	2.94e-05	2	189	2	30006565
Pubmed	Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.	C4A C4B	2.94e-05	2	189	2	6978711
Pubmed	Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.	C4A C4B	2.94e-05	2	189	2	35898513
Pubmed	Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.	C4A C4B	2.94e-05	2	189	2	28873507
Pubmed	c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathway.	CBL PIK3R1	2.94e-05	2	189	2	20133944
Pubmed	Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.	C4A C4B	2.94e-05	2	189	2	276882
Pubmed	Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.	C4A C4B	2.94e-05	2	189	2	6832377
Pubmed	Recombination of two homologous MHC class III genes of the mouse (C4 and Slp) that accounts for the loss of testosterone dependence of sex-limited protein expression.	C4A C4B	2.94e-05	2	189	2	3794341
Pubmed	Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3.	ENTPD1 ENTPD3	2.94e-05	2	189	2	20190036
Pubmed	CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden.	ITGAE ENTPD1	2.94e-05	2	189	2	36792124
Pubmed	Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes.	C4A C4B	2.94e-05	2	189	2	22785613
Pubmed	Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis.	C4A C4B	2.94e-05	2	189	2	32691186
Pubmed	Molecular cloning and expression of a novel klotho-related protein.	GBA3 KL	2.94e-05	2	189	2	11043382
Pubmed	The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter.	C4A C4B	2.94e-05	2	189	2	8390682
Pubmed	Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp).	C4A C4B	2.94e-05	2	189	2	3902619
Pubmed	Structural polymorphism of murine C4 and its linkage to H-2.	C4A C4B	2.94e-05	2	189	2	7373044
Pubmed	The chemical structure of the C4d fragment of the human complement component C4.	C4A C4B	2.94e-05	2	189	2	3696167
Interaction	CCT2 interactions	P4HA2 PLB1 WDR5B DYNC2I2 GAPDH OBSL1 COP1 CCT7 LRRK1 ITGA2B PIK3R4 GBA3 FBXW8 CDC40 TSR1 HPR BUB1B C9orf72 PCK1 DYNC1I1	3.18e-06	666	184	20	int:CCT2
Interaction	DNAJC7 interactions	GAPDH POLR2B OBSL1 PGD DIP2A GTF3C2 RSPH1 BUB1B FUNDC2 PLD5 HERC2 C9orf72 HERC4 DYNC1I1 HERC5	8.83e-06	425	184	15	int:DNAJC7
Cytoband	21q22.3	SLC37A1 ICOSLG DIP2A RSPH1 TRAPPC10	1.97e-04	128	189	5	21q22.3
Cytoband	12p13.3	CD163 SLC6A13 CD163L1	2.57e-04	30	189	3	12p13.3
GeneFamily	WD repeat domain containing	WDR64 WDR5B DYNC2I2 COP1 PIK3R4 FBXW8 GTF3C2 CDC40 TULP4 TLE6 IFT80 CFAP57 HERC1 DYNC1I1 TBL1X SEC13	4.65e-11	262	127	16	362
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA11 ITGA2B ITGAE ITGAM	6.58e-06	18	127	4	1160
GeneFamily	Complement system\|Sushi domain containing	ITGAM CFHR4 C4A C4B	1.15e-04	36	127	4	492
GeneFamily	Beta-gamma crystallin domain containing	CRYBG2 CRYBG1	1.46e-04	3	127	2	1360
GeneFamily	Solute carriers	SLC37A1 SLC5A10 SLC5A7 SLC35G6 SLC45A4 SLC6A9 SLC6A13 SLC35G3 SLC16A14 SLC5A8	4.78e-04	395	127	10	752
GeneFamily	Long pentraxins	NPTX1 NPTXR	4.83e-04	5	127	2	1142
GeneFamily	Fibronectin type III domain containing	CHL1 COL20A1 INSRR CMYA5 PTPRB LRRN4	9.37e-04	160	127	6	555
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	1.71e-03	9	127	2	1234
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ICOSLG ITGA2B ITGAE ITGAM CD163 TFRC CD1D CD101 ENTPD1	1.87e-03	394	127	9	471
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	BCAN PKD1L2 PKD1	2.97e-03	41	127	3	1298
GeneFamily	Kelch like\|BTB domain containing	IPP KLHL32 KLHL17	3.18e-03	42	127	3	617
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_500	RERG P4HA2 WNT2 RAPGEF4 SOCS3 RYR2 BUB1B PCK2	1.70e-05	129	184	8	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500	GABRB1 CHL1 RERG P4HA2 WNT2 RAPGEF4 SOCS3 ANGPTL1 RYR2 PTPRB ENTPD1 BUB1B LRRN4 PCK2	1.89e-05	420	184	14	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPM6 HDAC9 CNTNAP3B ACR RAPGEF4 CNTNAP3 HIF3A PTPRB TLL1 ENTPD1 HYAL2	3.41e-10	180	189	11	27e8bbee388e64dd79d70b160b76d45b1f398006
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 CNTNAP3B RAPGEF4 CNTNAP3 HIF3A PKHD1L1 PTPRB TLL1 ENTPD1 FGF6 HYAL2	9.91e-10	199	189	11	3a4deea6e11a0555d27497b7c9983350797aac69
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HDAC9 CNTNAP3B RAPGEF4 SOCS3 HIF3A PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.45e-08	199	189	10	53b6a661d381b1ed3ea96e61e8bd1750de7d9fda
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	HDAC9 CNTNAP3B RAPGEF4 SOCS3 HIF3A PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.45e-08	199	189	10	9c753043024871b1f1436fc39defac4da85e10cd
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 CNTNAP3B RAPGEF4 SOCS3 HIF3A PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.45e-08	199	189	10	d017dd91f9b10038f1f83753a766e534da2dbe89
ToppCell	Adult-Endothelial-endothelial_cell_of_vein\|Adult / Lineage, Cell type, age group and donor	HDAC9 CNTNAP3B ACR RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 HYAL2	6.68e-08	176	189	9	043683c61c5d1a7f8a4666a612310246bd3d83a2
ToppCell	Control-Endothelial_cells-Pulmonary_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	HDAC9 CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	9.33e-08	183	189	9	46be9f96755c7b65aeac061d95d15abeb6466034
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPM6 HDAC9 CNTNAP3B RAPGEF4 CNTNAP3 HIF3A PTPRB TLL1 ENTPD1	1.12e-07	187	189	9	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	SHANK1 HDAC9 RAPGEF4 INSRR ITGAM GIPR DUOX1 KL	1.32e-07	137	189	8	ed81624b9167255ce88dcf6ad7f1636376ea0525
ToppCell	PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	SHANK1 HDAC9 RAPGEF4 INSRR ITGAM GIPR DUOX1 KL	1.32e-07	137	189	8	47859aa25f32367461c1ec75ed9060bee430c6b7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 PLB1 LRRK1 ITGAM SFMBT2 CD163 CD163L1 ENTPD1 LOXL3	1.34e-07	191	189	9	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HDAC9 CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.47e-07	193	189	9	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.47e-07	193	189	9	287e756d5fd3bd2931c168da24beaa0d02a350ae
ToppCell	Endothelial-endothelial_cell_of_vein\|World / Lineage, Cell type, age group and donor	HDAC9 CNTNAP3B RAPGEF4 DGKE HIF3A PTPRB TLL1 ENTPD1 HYAL2	1.53e-07	194	189	9	3cbd9622a68e89add90e589867d88c83c5a33476
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 PLB1 LRRK1 ITGAM SFMBT2 CD163 CD163L1 ENTPD1 LOXL3	1.60e-07	195	189	9	34a9462f4e843f3065cc58c17ad71c1b5b836ae1
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.75e-07	197	189	9	b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HDAC9 CNTNAP3B ACR RAPGEF4 DGKE PTPRB SLC16A14 CD101	2.15e-07	146	189	8	df865558d1843f3857ebd1529cebc540d3554c59
ToppCell	Adult-Endothelial-endothelial_cell_of_vein-D122\|Adult / Lineage, Cell type, age group and donor	ACR RAPGEF4 HIF3A PKHD1L1 PTPRB NPTXR TLL1 HYAL2	4.32e-07	160	189	8	0cfe130606af433b2aa90e0a20b6c44659dd6fd4
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPM6 HDAC9 CNTNAP3B RAPGEF4 CNTNAP3 HIF3A PTPRB TLL1	5.99e-07	167	189	8	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	droplet-Heart-HEART-1m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PGLYRP1 WNT2 ACR PKHD1L1 SFMBT2 ACSL3 TLL1 ZG16	7.82e-07	173	189	8	9dc7746a84f0e268a7c061e1bbcd5e31903034dc
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CHL1 CNTNAP3B CNTNAP3 SLC45A4 KL PTPRB ENTPD1 CRYBG1	9.69e-07	178	189	8	c227da59dc7beb73f84405bf13356bdeb59d9338
ToppCell	wk_15-18-Mesenchymal-Mesothelial-intermediate_mesothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DSPP PKHD1L1 TGM5 TG SLC6A13 C4A LRRN4 MUCL3	1.01e-06	179	189	8	b1f085e4c8d65d5cdbfaf2db80343638abb08979
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PGLYRP1 WNT2 PKHD1L1 PTPRB TLL1 ENTPD1 PLD5 HYAL2	1.10e-06	181	189	8	cef034030e6b029a49ae56be37ea1fac1a5c350e
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HDAC9 CNTNAP3B RAPGEF4 DGKE PTPRB TLL1 ENTPD1 HYAL2	1.10e-06	181	189	8	2c660fcf0404c155955b67ab2958d6e6b0e30024
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	HDAC9 CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 HYAL2	1.40e-06	187	189	8	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	HDAC9 CNTNAP3B RAPGEF4 PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.46e-06	188	189	8	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B RAPGEF4 CNTNAP3 HIF3A PKHD1L1 PTPRB TLL1 DYNC1I1	1.46e-06	188	189	8	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B RAPGEF4 CNTNAP3 HIF3A PTPRB HMCN2 SLC16A14 ENTPD1	1.52e-06	189	189	8	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B RAPGEF4 CNTNAP3 HIF3A PKHD1L1 PTPRB TLL1 DYNC1I1	1.58e-06	190	189	8	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 CNTNAP3B RAPGEF4 PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.58e-06	190	189	8	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 PLB1 LRRK1 ITGAM SFMBT2 CD163 CD163L1 LOXL3	1.58e-06	190	189	8	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	CNTNAP3B RAPGEF4 CNTNAP3 HIF3A PKHD1L1 PTPRB TLL1 DYNC1I1	1.58e-06	190	189	8	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HDAC9 RAPGEF4 SOCS3 HIF3A PKHD1L1 PTPRB ENTPD1 HYAL2	1.78e-06	193	189	8	682ce63b73a7d02eef240673db67058d7507f744
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HDAC9 RAPGEF4 SOCS3 HIF3A PKHD1L1 PTPRB ENTPD1 HYAL2	1.78e-06	193	189	8	c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic-LEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTNAP3B CNTNAP3 HIF3A PKHD1L1 PTPRB TLL1 DYNC1I1 HYAL2	1.85e-06	194	189	8	f772a9f9ef8635aeaeb8b022dbb94e9672b36ead
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 PLB1 LRRK1 ITGAM SFMBT2 CD163 CD163L1 LOXL3	1.85e-06	194	189	8	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTNAP3B CNTNAP3 HIF3A PKHD1L1 PTPRB TLL1 DYNC1I1 HYAL2	1.85e-06	194	189	8	3b73f2d305a7566f7ab567e5f18c82cd3d80e32c
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HDAC9 CNTNAP3B RAPGEF4 DGKE PTPRB TLL1 ENTPD1 HYAL2	1.85e-06	194	189	8	fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTNAP3B CNTNAP3 HIF3A PKHD1L1 PTPRB TLL1 DYNC1I1 HYAL2	1.85e-06	194	189	8	5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B HIF3A PTPRB HMCN2 SLC16A14 ENTPD1 PLD5 HYAL2	1.92e-06	195	189	8	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HDAC9 CNTNAP3B RAPGEF4 DGKE HIF3A PKHD1L1 PTPRB TLL1	1.92e-06	195	189	8	81a98ebb0d43f416f9a8bba580531dc0cfea8f74
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.99e-06	196	189	8	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	Adult-Immune-monocyte-D122\|Adult / Lineage, Cell type, age group and donor	HDAC9 PLB1 MANBA ITGAM CD163 CD1D ENTPD1 LOXL3	1.99e-06	196	189	8	16b0acb6157534938ca83d4e909471e33a7d3c52
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 PLB1 LRRK1 ITGAM CD163 CD163L1 ENTPD1 LOXL3	1.99e-06	196	189	8	4370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CNTNAP3B ACR RAPGEF4 SOCS3 PKHD1L1 PTPRB SLC35G3 HYAL2	2.07e-06	197	189	8	1a137af40697137bb9d2b5caf2b1ffda55f04461
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CNTNAP3B ACR RAPGEF4 SOCS3 PKHD1L1 PTPRB SLC35G3 HYAL2	2.07e-06	197	189	8	f969685dee212f33a6f09e54c0cd1fd24ffef546
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CNTNAP3B ACR RAPGEF4 SOCS3 PKHD1L1 PTPRB SLC35G3 HYAL2	2.07e-06	197	189	8	96d63a8d00583e2aa0a38412e2ae27e23f399493
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HDAC9 RAPGEF4 SOCS3 HIF3A PKHD1L1 PTPRB ENTPD1 HYAL2	2.15e-06	198	189	8	3ae1e2b4ca77b94eaa24a8c990780aff47dface6
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B CNTNAP3 HIF3A PKHD1L1 LOXHD1 PTPRB TLL1 DYNC1I1	2.15e-06	198	189	8	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HDAC9 RAPGEF4 SOCS3 HIF3A PKHD1L1 PTPRB ENTPD1 HYAL2	2.15e-06	198	189	8	71ee440b1ac566db63d0b415c50a0ad064d14f15
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 PLB1 LRRK1 ITGAM SFMBT2 CD163 CD163L1 ENTPD1	2.15e-06	198	189	8	96883ad8e189a46ed5b7eaafc0543e53682d26ed
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B CNTNAP3 HIF3A PKHD1L1 LOXHD1 PTPRB TLL1 DYNC1I1	2.15e-06	198	189	8	b3a020522e064bb61949d38e442f24026e339364
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HDAC9 RAPGEF4 SOCS3 HIF3A PKHD1L1 PTPRB ENTPD1 HYAL2	2.15e-06	198	189	8	fb70a649e4e2edb32967328c1085dc5999c29a33
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PGLYRP1 LCT ITGAM PGD SLC6A13 LOXHD1 CD101	2.32e-06	140	189	7	90298cac4bcec614a48e60b5c139c86daa9f0321
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PGLYRP1 LCT ITGAM PGD SLC6A13 LOXHD1 CD101	2.32e-06	140	189	7	671ab1f5cbd8568bf93ebdf961c2a1ede06d2bcb
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRPM6 CNTNAP3B NPTX1 PGLYRP1 CNTNAP3 SLC45A4 PTPRB	2.55e-06	142	189	7	191a13bba143ecdfc2bfd797c3ac191481388298
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TRPM6 CNTNAP3B NPTX1 PGLYRP1 CNTNAP3 SLC45A4 PTPRB	2.67e-06	143	189	7	b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HDAC9 CNTNAP3B ACR CNTNAP3 DGKE PTPRB SLC16A14	2.79e-06	144	189	7	748f4efc59f7afbce6c497524f36d852b8b1d637
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HDAC9 CNTNAP3B RAPGEF4 SOCS3 DGKE PTPRB TLL1	3.66e-06	150	189	7	4f31867cb85253ff6d22f3b02ef972a42cb41123
ToppCell	droplet-Lung-LUNG-1m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PGLYRP4 PGLYRP1 LCT PGD SFMBT2 SLC6A13 CD101	5.16e-06	158	189	7	30cceb73cf5e24b692da84d33342fd3b1ad5efe5
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PGLYRP4 PGLYRP1 LCT PGD SFMBT2 SLC6A13 CD101	5.16e-06	158	189	7	47793463640f98ee5f680a1ee5786b453355fd57
ToppCell	droplet-Lung-1m-Hematologic-myeloid-neutrophil-neutrophil\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PGLYRP1 ITGAM PGD SLC6A13 CD101 ENTPD1 ENTPD3	5.38e-06	159	189	7	be54b910ccb73e37eb81945bbad9a89d2bcec34b
ToppCell	droplet-Lung-1m-Hematologic-myeloid-neutrophil\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PGLYRP1 ITGAM PGD SLC6A13 CD101 ENTPD1 ENTPD3	5.38e-06	159	189	7	178678173b005cb8225472306657f0d8289b133b
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7\|Thalamus / BrainAtlas - Mouse McCarroll V32	SLC37A1 NPTX1 INSRR SLC5A7 DNAH1 NWD2 TLL1	5.60e-06	160	189	7	7d34159363d274019e14549d1186c629ce990691
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2\|Thalamus / BrainAtlas - Mouse McCarroll V32	SLC37A1 NPTX1 INSRR SLC5A7 DNAH1 NWD2 TLL1	5.60e-06	160	189	7	fe5fb0e7a79862f63529721f0a82f4f6d231d3ca
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHANK1 WDR64 MYO9A ITIH4 RYR2 SLC6A9 ZG16	5.84e-06	161	189	7	b9a17f41426bf715f30bf544a6795afaf37a3aa6
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHANK1 WDR64 MYO9A ITIH4 RYR2 SLC6A9 ZG16	5.84e-06	161	189	7	f7a89c481f789f624102857be722c95fbeb47595
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 ITGA11 RAPGEF4 SLC5A7 TG ATP11C CD200R1L	5.84e-06	161	189	7	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACR SOCS3 PTPRB TLL1 ENTPD1 EDEM2 DYNC1I1	7.71e-06	168	189	7	32e4d82efaccf336d347e4063253c3635a3ec672
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPM4 ITGA11 INSRR FBXW8 NWD2 CD163L1 PLD5	8.33e-06	170	189	7	6af7dee9b8298d4499e05a82cf9cdfe3bd81d384
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	CNTNAP3B CNTNAP3 HIF3A PKHD1L1 PTPRB TLL1 DYNC1I1	9.34e-06	173	189	7	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B TRPM4 RERG ITGA11 NWD2 CD163L1 TLL1	1.12e-05	178	189	7	e4e11e4940c911c17806200c25096928153c684d
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CHL1 HDAC9 CNTNAP3B CNTNAP3 RYR2 ENTPD1 CFAP57	1.17e-05	179	189	7	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHANK1 ZNF609 RYR2 NWD2 TLL1 PLD5 DYNC1I1	1.21e-05	180	189	7	f6a2208960d0df1500c974cc44c3c054cd7475a9
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	RALGAPA1 RAPGEF6 TFRC AP1G1 CRYBG1 HERC1 HERC4	1.25e-05	181	189	7	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRPM6 CRYBG2 SLC5A10 PGLYRP1 ITGAM HPR CD101	1.30e-05	182	189	7	52eac2f892ea7f26731e0b21c578fd2665a1657a
ToppCell	5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WNT2 CNTNAP3 HIF3A PKHD1L1 TLL1 DYNC1I1 HYAL2	1.35e-05	183	189	7	2d0d3b486498a7903fa9a1f48b189291da49c430
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HDAC9 RAPGEF4 DGKE PTPRB TLL1 ENTPD1 HYAL2	1.35e-05	183	189	7	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CHL1 CNTNAP3B CNTNAP3 SLC45A4 KL PTPRB ENTPD1	1.39e-05	184	189	7	a809b0fa52df8a159f60f87eefcef61220af5e34
ToppCell	COPD-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	RERG PKHD1L1 HPR DIP2C C4A C4B PCK1	1.44e-05	185	189	7	23579988036fc1925992c31919750f9b3fe9f790
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RERG OBSL1 CD163L1 ENTPD3 PLD5 SLC5A8 TBL1X	1.44e-05	185	189	7	0b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHANK1 GRM8 RYR2 NWD2 TLL1 PLD5 DYNC1I1	1.55e-05	187	189	7	7b2cd0c618ed081223343f3bec2244c8723c9a31
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175\|Adult / Lineage, Cell type, age group and donor	CNTNAP3B RAPGEF4 CNTNAP3 HIF3A PKHD1L1 PTPRB TLL1	1.55e-05	187	189	7	1e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	CHL1 CNTNAP3B RAPGEF4 HIF3A SLC45A4 PTPRB TLL1	1.60e-05	188	189	7	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	Endothelial-endothelial_cell_of_lymph_vessel\|World / Lineage, Cell type, age group and donor	CNTNAP3B RAPGEF4 CNTNAP3 PKHD1L1 PTPRB TLL1 HYAL2	1.60e-05	188	189	7	80910dcbb51990f2baed240f319456c0d3fa2065
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B HIF3A PKHD1L1 PTPRB TLL1 DYNC1I1 HYAL2	1.60e-05	188	189	7	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CNTNAP3B RAPGEF4 CNTNAP3 PKHD1L1 PTPRB SCAMP5 HYAL2	1.66e-05	189	189	7	0d18ea72bd58d32a8ab9a61cf97f5786642f804b
ToppCell	Control-Endothelial-VE_Venous\|World / Disease state, Lineage and Cell class	CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 HYAL2	1.66e-05	189	189	7	f83f7521e377ded1522639e9a35c98b3e2725bac
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CNTNAP3B RAPGEF4 CNTNAP3 PKHD1L1 PTPRB TLL1 HYAL2	1.66e-05	189	189	7	55a1776a4ce049959b3f13a43744c7314bc1f00a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B RAPGEF4 PKHD1L1 PTPRB TLL1 ENTPD1 HYAL2	1.71e-05	190	189	7	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	COVID-19-lung-Artery_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CHL1 RAPGEF4 HIF3A SLC45A4 PTPRB TLL1 ENTPD1	1.71e-05	190	189	7	07b675befcd1d0a9c90cb17b5d22323468325d51
ToppCell	IPF-Endothelial-Lymphatic\|World / Disease state, Lineage and Cell class	CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 HYAL2	1.71e-05	190	189	7	ac029e73da5995221c9b9af551d85e4b835e21d6
ToppCell	Control-Endothelial-VE_Venous\|Control / Disease state, Lineage and Cell class	CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 HYAL2	1.77e-05	191	189	7	617546cf4883dedf3323e03a53ba5adec334cf8e
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	CNTNAP3B RAPGEF4 CNTNAP3 PKHD1L1 PTPRB TLL1 ENTPD1	1.83e-05	192	189	7	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 RAPGEF4 SFMBT2 PTPRB TLL1 ENTPD1 HYAL2	1.83e-05	192	189	7	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Vein\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 RAPGEF4 SFMBT2 PTPRB TLL1 ENTPD1 HYAL2	1.83e-05	192	189	7	81baf1c4063469bb0c03a8602b40e387ba7b0dfb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B RAPGEF4 DGKE PTPRB HMCN2 ENTPD1 HYAL2	1.83e-05	192	189	7	3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B RAPGEF4 HIF3A PTPRB TLL1 ENTPD1 HYAL2	1.83e-05	192	189	7	28eb3a5728e8901bcb5ba12f6b009f41b065fa37
ToppCell	IPF-Endothelial-Lymphatic\|IPF / Disease state, Lineage and Cell class	CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 HYAL2	1.83e-05	192	189	7	2496edd8f3a41146d418879de9ee2ccc7857431f
ToppCell	Control-Endothelial-Lymphatic\|World / Disease state, Lineage and Cell class	CNTNAP3B RAPGEF4 HIF3A PKHD1L1 PTPRB TLL1 HYAL2	1.83e-05	192	189	7	f95fb188aa642f3d0618242a770e7c4b70544adb
Computational	Glycolysis and TCA cycle.	GAPDH ACO2 PCK1 PCK2	1.55e-04	26	115	4	MODULE_306
Computational	Neighborhood of CALM1	RALGAPA1 KDM3B GBA2 ACSL3 SCAMP5 HERC2 GPRASP2	1.71e-04	110	115	7	GCM_CALM1
Drug	doxorubicinol	WNT2 ACO2 SOCS3 RYR2 TFRC	1.03e-06	23	186	5	CID000083970
Drug	cathenamine	GBA2 GBA3 C4A	2.13e-06	4	186	3	CID000443361
Drug	NSC-7616	WNT2 ACO2 ITIH4 TFRC SLC35G3 PCK2	3.23e-06	50	186	6	CID000000309
Drug	p-nitrophenyl-alpha-D-glucopyranoside	GALC MANBA DSPP LCT GBA2 GBA3 KL PCK2	5.11e-06	116	186	8	CID000065115
Drug	fagomine	MANBA LCT GBA2 GBA3	9.44e-06	17	186	4	CID000072259
Drug	5-amino-5-deoxy-D-mannopyranose	MANBA GBA2 GBA3	1.05e-05	6	186	3	CID000124624
Drug	AC1NSXES	GBA2 GBA3 SLC5A8	1.05e-05	6	186	3	CID005318890
Drug	riboxin	ENTPD1 ENTPD3 PCK1 PCK2 ENTPD8	1.06e-05	36	186	5	CID000006831
Drug	glucose-6-P	MANBA GAPDH ACO2 GBA2 PGD PLBD2 TFRC TG PIK3R4 GBA3 KL AP1G1 PCK2	1.06e-05	366	186	13	CID000000208
Drug	4-methylumbelliferyl-beta-D-glucopyranoside	GALC MANBA LCT GBA2 GBA3	1.22e-05	37	186	5	CID000087330
Drug	Laevuflex	GAPDH ACR ITGA2B LCT GBA2 PGD GBA3 HPR HERC1 PCK1 PCK2	1.56e-05	272	186	11	CID000003426
Drug	Plantagoside	MANBA GBA2 GBA3	1.83e-05	7	186	3	CID000174157
Drug	convicine	GAPDH GBA2 GBA3	1.83e-05	7	186	3	CID000088000
Drug	DN-9693	ENTPD1 ENTPD3 ALDH7A1	1.83e-05	7	186	3	CID000121868
Drug	ginsenoside Rb1	SLC5A7 GBA2 GBA3 PIK3R1 C4A	2.04e-05	41	186	5	CID000073148
Drug	1-deoxynojirimycin hydrochloride	GALC MANBA ADGRL1 LCT GBA2 ITIH4 GBA3	2.08e-05	102	186	7	CID000001374
Drug	AC1L3M3Y	GALC MANBA GAPDH GBA2 GBA3	2.30e-05	42	186	5	CID000091455
Drug	NSC624987	MANBA LCT GBA2 GBA3	2.81e-05	22	186	4	CID000001472
Drug	AC1LCZV5	GBA2 GBA3 C4A	2.92e-05	8	186	3	CID000640056
Drug	pyridoxine-5'-beta-D-glucoside	LCT GBA2 GBA3	2.92e-05	8	186	3	CID000440188
Drug	enantio-PAF-C16	PLB1 ITGAM PIK3R4 SLC6A13 KL ENTPD1 ENTPD3 C4A ART5 ALDH7A1	3.42e-05	244	186	10	CID000002499
Drug	acetate	MANBA GAPDH ACR ACO2 GBA2 PGD PLBD2 DNAH1 GBA3 PTPRB PIK3R1 HPR SLC5A8 PCK1 PCK2 ALDH7A1	3.52e-05	599	186	16	CID000000175
Drug	AC1L9HP3	DSPP ARF4 TG PIK3R4 ALG6 SEC13	3.73e-05	76	186	6	CID000445265
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A	TRPM4 ICOSLG CRYBG2 NPTX1 DSPP GIPR SLC6A13 FGF6 MAGEC1	3.81e-05	198	186	9	7473_UP
Drug	AGEPC	GABRB1 GABRD PLB1 ITGA2B ITGAM GBA3 KL ENTPD1 ENTPD3 C4A ART5 ALDH7A1	3.88e-05	356	186	12	CID000461545
Drug	rhamnose	GALC ACR BCAN LCT ITGAM GBA2 PGD ITIH4 TG GBA3 TSR1 HPR	3.88e-05	356	186	12	CID000000840
Drug	poly I	ACO2 POLR2B ITGAM DUOX1 HPR ASL ENTPD1 ENTPD3 SPPL2C ENTPD8	4.20e-05	250	186	10	CID000000797
Drug	N-bromosuccinamide	MANBA GBA2 GBA3	4.35e-05	9	186	3	CID009834204
Drug	cppc	GAPDH PCK1 PCK2	4.35e-05	9	186	3	CID000016521
Drug	conduritol B	LCT GBA2 GBA3	4.35e-05	9	186	3	CID000065317
Drug	AC1L1IFV	TRPM6 P4HA2 GAPDH LCT KL ENTPD1	4.65e-05	79	186	6	CID000004561
Drug	62 p	DSPP ITGA2B ITGAM PIK3R4 ALDH7A1	4.91e-05	49	186	5	CID006420118
Drug	trigalacturonate	TRPM6 MANBA GBA2 GBA3 HYAL2	5.42e-05	50	186	5	CID000439239
Drug	(2s,5s)-5-Carboxymethylproline	UIMC1 ITGA11 CENPB ITGA2B ITGAE ITGAM GRM8 TG PIK3R4 KL MAGEC1	5.80e-05	314	186	11	CID000447989
Drug	AC1LCY75	LCT GBA3 C4A	6.17e-05	10	186	3	CID000639298
Drug	AC1MRQ63	GBA2 GBA3 ALDH7A1	6.17e-05	10	186	3	CID003496897
Drug	NSC106556	GBA2 GBA3	6.64e-05	2	186	2	CID000267363
Drug	allylacetylene	GBA2 GBA3	6.64e-05	2	186	2	CID000522708
Drug	R-G-P-G	ITIH4 C4A	6.64e-05	2	186	2	CID000485269
Drug	oxarbazole	DSPP C4A	6.64e-05	2	186	2	CID000037184
Drug	AC1L3ZSY	GBA2 GBA3	6.64e-05	2	186	2	CID000098102
Drug	1-hydroxy-3,7-dimethoxyxanthone	GBA2 GBA3	6.64e-05	2	186	2	CID005488808
Drug	benzene-butanol	GBA2 GBA3	6.64e-05	2	186	2	CID000076889
Drug	torvanol A	GBA2 GBA3	6.64e-05	2	186	2	CID000639650
Drug	8-Hydroxyquinoline-beta-D-glucoside	GBA2 GBA3	6.64e-05	2	186	2	CID000152983
Drug	Ccris 6118	GBA2 GBA3	6.64e-05	2	186	2	CID003085143
Drug	3alpha-dihydrocadambine	GBA2 GBA3	6.64e-05	2	186	2	CID000162138
Drug	avenacoside B	GBA2 GBA3	6.64e-05	2	186	2	CID000441878
Drug	glucocheirolin	GBA2 GBA3	6.64e-05	2	186	2	CID000656530
Drug	AC1NSZ0V	GBA2 GBA3	6.64e-05	2	186	2	CID005320067
Drug	balanitoside	GBA2 GBA3	6.64e-05	2	186	2	CID000150711
Drug	3-mat	GBA2 GBA3	6.64e-05	2	186	2	CID006453430
Drug	AC1LDLNP	GBA2 GBA3	6.64e-05	2	186	2	CID000620782
Drug	Purin-6-yl 6-deoxy-1-thio-beta-D-glucopyranoside	GBA2 GBA3	6.64e-05	2	186	2	CID000130740
Drug	3beta-isodihydrocadambine	GBA2 GBA3	6.64e-05	2	186	2	CID000188431
Drug	phenthoate oxon	GBA2 GBA3	6.64e-05	2	186	2	CID000019398
Drug	Ambap529-66-8	GBA2 GBA3	6.64e-05	2	186	2	CID003083619
Drug	DIMBOA-glucoside	GBA2 GBA3	6.64e-05	2	186	2	CID000441563
Drug	glucoside 1	GBA2 GBA3	6.64e-05	2	186	2	CID006325268
Drug	theaspirane	GBA2 GBA3	6.64e-05	2	186	2	CID000061953
Drug	dimethylbellidifolin	GBA2 GBA3	6.64e-05	2	186	2	CID005487856
Drug	3,4,6-tri-O-methyl-D-glucose	GBA2 GBA3	6.64e-05	2	186	2	CID000193713
Drug	luteone	GBA2 GBA3	6.64e-05	2	186	2	CID005281797
Drug	GH 9	GBA2 GBA3 HYAL2	8.44e-05	11	186	3	CID005488162
Drug	CPPP	HPR ENTPD1 ENTPD3	8.44e-05	11	186	3	CID000195490
Drug	linalool	SOCS3 GBA2 GBA3 SLC5A8	8.73e-05	29	186	4	CID000006549
Drug	AMP group	RAPGEF6 GAPDH RAPGEF4 ADGRL1 DGKE TG ACSL3 ASL ENTPD1 ENTPD3 ART5 PCK2 DYNC1I1 ENTPD8 ALDH7A1	8.74e-05	579	186	15	CID000000224
Drug	quercetin-4'-glucoside	LCT GBA2 GBA3	1.12e-04	12	186	3	CID005320844
Drug	8a beta-indolizidine-1 alpha, 2 alpha, 8 beta-triol	MANBA ADGRL1 LCT GBA2 ITIH4 GBA3	1.23e-04	94	186	6	CID000005363
Drug	NSC-614841	ITIH4 CD163 C4A	1.44e-04	13	186	3	CID000357070
Drug	MDL 25,637	LCT GBA2 GBA3	1.44e-04	13	186	3	CID000128548
Drug	cast 3	MANBA GBA2 GBA3	1.44e-04	13	186	3	CID000072360
Drug	miglustat	LCT GBA2 ITIH4 TG GBA3 CD1D	1.46e-04	97	186	6	CID000051634
Drug	daidzin	LCT GBA2 GBA3 ALDH7A1	1.47e-04	33	186	4	CID000107971
Drug	AC1OAGFB	TRPM4 COL20A1 RAPGEF4 CBLC DGKE CBL ARF4 ARF5 TFRC TG PIK3R1 HERC1 ART5 TBL1X	1.47e-04	539	186	14	CID006857345
Drug	H S Q	GALC MANBA PGLYRP1 BCAN GBA2 ITIH4 TG GBA3 KL ALG6 HYAL2	1.55e-04	351	186	11	CID000000897
Drug	Rgd Peptide	CHL1 ITGA11 DSPP ITGA2B ITGAE ITGAM PIK3R4 ENTPD1 ENTPD3	1.61e-04	239	186	9	CID000104802
Drug	longum	MANBA LCT ITGAE GBA2 GBA3	1.65e-04	63	186	5	CID000009047
Drug	baclofen	GABRB1 GABRD DSPP GRM8 RYR2 SLC6A13 PKD1 ART5	1.81e-04	191	186	8	CID000002284
Drug	2-chloro-4-nitrophenol	GAPDH GBA2 GBA3	1.83e-04	14	186	3	CID000012074
Drug	AC1NSXE4	GBA2 GBA3 SLC5A8	1.83e-04	14	186	3	CID005318881
Drug	indole-3-acetyl-l-valine	ITGA11 ITGA2B ITGAE ITGAM PIK3R4	1.91e-04	65	186	5	CID000446641
Drug	AC1L3VFE	LCT GBA2 GBA3 C4A ALDH7A1	1.91e-04	65	186	5	CID000122880
Drug	NSC103055	GBA2 GBA3	1.98e-04	3	186	2	CID000266052
Drug	thiophosphoenolpyruvate	PCK1 PCK2	1.98e-04	3	186	2	CID000146003
Drug	NSC-167733	SOCS3 TG	1.98e-04	3	186	2	CID000062281
Drug	torvoside H	GBA2 GBA3	1.98e-04	3	186	2	CID000639649
Drug	NSC721382	GBA2 GBA3	1.98e-04	3	186	2	CID000404838
Drug	2',4'-dinitrophenyl beta-D-galactopyranoside	GBA2 GBA3	1.98e-04	3	186	2	CID000152809
Drug	AC1Q5X08	GBA2 GBA3	1.98e-04	3	186	2	CID000125153
Drug	FU-O-G	GBA2 GBA3	1.98e-04	3	186	2	CID000125172
Drug	protogracillin	GBA2 GBA3	1.98e-04	3	186	2	CID000441892
Drug	2-aminothiophenol	C4A C4B	1.98e-04	3	186	2	ctd:C005464
Drug	bioside	GBA2 GBA3	1.98e-04	3	186	2	CID003084119
Drug	AC1L2O6A	GBA2 GBA3	1.98e-04	3	186	2	CID000100152
Drug	(5S,6R,7S,8R)-5-methylol-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-6,7,8-triol	MANBA GBA3	1.98e-04	3	186	2	CID009990375
Drug	Cellobiose octaacetate	GBA2 GBA3	1.98e-04	3	186	2	CID000104455
Drug	phloroglucinaldehyde	GBA2 GBA3	1.98e-04	3	186	2	CID000068099
Drug	6-bromo-2-naphthyl-beta-d-glucoside	GBA2 GBA3	1.98e-04	3	186	2	CID000084983
Drug	3'-galactosyllactose	GBA2 GBA3	1.98e-04	3	186	2	CID000189088
Disease	Schizophrenia	GABRB1 CHL1 SHANK1 GABRD HDAC9 RAPGEF6 SRD5A2 BACE1 CMYA5 ITGAM GRM8 CD163 SLC6A9 EDEM2 MAGEC1 C9orf72 PCK1 KPNA3	9.17e-06	883	181	18	C0036341
Disease	Phosphoenolpyruvate carboxykinase deficiency	PCK1 PCK2	3.74e-05	2	181	2	C0268194
Disease	aspartate aminotransferase measurement	P4HA2 PLB1 RAPGEF6 SRD5A2 IPP LCT CD163 SLC45A4 GBA3 DGLUCY NPHP3 HMCN2 ERAP2 PIK3R1 HPR EDEM2 IFT80	4.52e-05	904	181	17	EFO_0004736
Disease	autistic disorder (is_implicated_in)	GABRB1 RAPGEF4 GRM8 C4B	1.28e-04	42	181	4	DOID:12849 (is_implicated_in)
Disease	Autistic Disorder	GABRB1 SHANK1 WNT2 COP1 GRM8 SCAMP5 C4B PLD5	2.21e-04	261	181	8	C0004352
Disease	kallikrein-7 measurement	CD163 CD163L1	3.70e-04	5	181	2	EFO_0008195
Disease	Short rib-polydactyly syndrome, Verma-Naumoff type	DYNC2I2 IFT80	3.70e-04	5	181	2	C0432197
Disease	eye colour measurement	HDAC9 RERG CNTNAP3 PLBD2 NWD2 CRYBG1 HERC2	4.14e-04	218	181	7	EFO_0009764
Disease	complement factor H-related protein 2 measurement	CHL1 CFHR4 DYNC1I1	7.38e-04	29	181	3	EFO_0600055
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3	1.02e-03	8	181	2	DOID:0060308 (implicated_via_orthology)
Disease	body shape measurement	GRM8 TRAP1	1.02e-03	8	181	2	EFO_0801227
Disease	Complement deficiency disease	CFHR4 C4A C4B	1.08e-03	33	181	3	C0272242
Disease	Liver carcinoma	GABRD GAPDH ACO2 SOCS3 PGD CD163 GBA3 BUB1B PCK1 HERC5	1.22e-03	507	181	10	C2239176
Disease	alkaline phosphatase measurement	RALGAPA1 MANBA SRD5A2 ERMP1 ITIH4 CFHR4 NWD2 NPHP3 ASL EDEM2 PKD1 FGF6 PCK1 RIC1 KLHL17	1.55e-03	1015	181	15	EFO_0004533
Disease	Congenital myasthenic syndrome	MYO9A SLC5A7	1.63e-03	10	181	2	cv:C0751882
Disease	abdominal aortic calcification measurement	HDAC9 PIK3R4	1.63e-03	10	181	2	EFO_0010272
Disease	Graves' disease (is_implicated_in)	TG C4A C4B	1.76e-03	39	181	3	DOID:12361 (is_implicated_in)
Disease	platelet-to-lymphocyte ratio	HDAC9 MANBA ACO2 PSMB9 ITGA2B CBL PGD TNKS1BP1	1.88e-03	363	181	8	EFO_0008446
Disease	Jeune thoracic dystrophy	DYNC2I2 IFT80	1.98e-03	11	181	2	C0265275
Disease	osteosarcoma (is_marker_for)	CBL PTPRB	1.98e-03	11	181	2	DOID:3347 (is_marker_for)
Disease	kidney disease (implicated_via_orthology)	LCT GBA3 KL	2.04e-03	41	181	3	DOID:557 (implicated_via_orthology)
Disease	respiratory system disease	ACO2 SOCS3 ERMP1 TFRC RIC1	2.05e-03	145	181	5	EFO_0000684
Disease	S-6-hydroxywarfarin to S-warfarin ratio measurement	SRD5A2 TFRC HERC4 PCK1	2.14e-03	88	181	4	EFO_0803332
Disease	serum metabolite measurement	GABRB1 RALGAPA1 PKD1L1 IPP ERMP1 PKD1L2 ITGAM SLC45A4 GBA3 SLC6A13 NWD2 ERAP2 DIP2C RIC1	2.16e-03	945	181	14	EFO_0005653
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	SOCS3 ITGAM KL PIK3R1 HPR	2.18e-03	147	181	5	DOID:9352 (biomarker_via_orthology)
Disease	obesity (biomarker_via_orthology)	GAPDH SOCS3 ITIH4 PIK3R1 HPR	2.18e-03	147	181	5	DOID:9970 (biomarker_via_orthology)
Disease	autoimmune thyroiditis (is_implicated_in)	PSMB9 TG	2.37e-03	12	181	2	DOID:7188 (is_implicated_in)
Disease	Anxiety States, Neurotic	SHANK1 GRM8 TG	2.50e-03	44	181	3	C0376280
Disease	Anxiety neurosis (finding)	SHANK1 GRM8 TG	2.50e-03	44	181	3	C1279420
Disease	Anxiety Disorders	SHANK1 GRM8 TG	2.50e-03	44	181	3	C0003469
Disease	autism spectrum disorder (implicated_via_orthology)	SHANK1 CNTNAP3B CNTNAP3 SCAMP5 GPRASP2	2.52e-03	152	181	5	DOID:0060041 (implicated_via_orthology)
Disease	hypothyroidism (implicated_via_orthology)	TG DUOX1	2.79e-03	13	181	2	DOID:1459 (implicated_via_orthology)
Disease	prostate cancer (is_marker_for)	WNT2 SRD5A2 TFRC ACSL3 PIK3R1	2.81e-03	156	181	5	DOID:10283 (is_marker_for)
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	NPHP3 PKD1	3.24e-03	14	181	2	DOID:898 (implicated_via_orthology)
Disease	triacylglycerol 48:4 measurement	SFMBT2 PLD5	3.24e-03	14	181	2	EFO_0010407
Disease	congenital hypothyroidism (implicated_via_orthology)	TG DUOX1	3.24e-03	14	181	2	DOID:0050328 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	CHL1 GRM8 SCAMP5 KCNK17 ALDH7A1	3.40e-03	163	181	5	DOID:1826 (implicated_via_orthology)
Disease	creatinine measurement	RERG P4HA2 MANBA GIPR SLC6A13 DUOX1 SPPL2A PIK3R1 EDEM2 DIP2C FGF6 CFAP57 PCK1 KPNA3	3.44e-03	995	181	14	EFO_0004518
Disease	2-hydroxyglutarate measurement	DGLUCY PLD5	4.24e-03	16	181	2	EFO_0021506
Disease	myopia (is_implicated_in)	P4HA2 LOXL3	4.24e-03	16	181	2	DOID:11830 (is_implicated_in)
Disease	amygdala volume change measurement	GABRB1 PKD1L1	4.24e-03	16	181	2	EFO_0021490
Disease	Abnormal behavior	KDM3B SCAMP5	4.24e-03	16	181	2	C0233514
Disease	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	HDAC9 HIF3A PTPRB	4.48e-03	54	181	3	EFO_0000180, EFO_0003100, GO_0061479
Disease	Ischemic stroke, fibrinogen measurement	HDAC9 RAPGEF6 SPPL2A	4.71e-03	55	181	3	EFO_0004623, HP_0002140
Disease	Respiratory Distress Syndrome, Adult	GABRB1 ACO2 LCT	4.71e-03	55	181	3	C0035222
Disease	S-7-hydroxywarfarin measurement	TGM5 PIK3R1 FGF6 HERC4	4.77e-03	110	181	4	EFO_0803329
Disease	Unipolar Depression	HDAC9 SLC5A7 CMYA5 TG SLC6A13 KPNA3	5.41e-03	259	181	6	C0041696
Disease	creatine kinase measurement	SOCS3 CD163 CD163L1	5.74e-03	59	181	3	EFO_0004534
Disease	breast cancer (is_marker_for)	RERG WNT2 KDM3B TFRC ACSL3	5.79e-03	185	181	5	DOID:1612 (is_marker_for)
Disease	creatinine measurement, glomerular filtration rate	RERG MANBA SLC6A13 PIK3R1	5.93e-03	117	181	4	EFO_0004518, EFO_0005208
Disease	Congenital Myasthenic Syndromes, Presynaptic	MYO9A SLC5A7	5.97e-03	19	181	2	C0751884
Disease	type 1 diabetes mellitus (biomarker_via_orthology)	CBL HPR	5.97e-03	19	181	2	DOID:9744 (biomarker_via_orthology)
Disease	Insulin Resistance	ITGAM CD163 PIK3R1	6.01e-03	60	181	3	C0021655
Disease	Insulin Sensitivity	ITGAM CD163 PIK3R1	6.01e-03	60	181	3	C0920563

Protein segments in the cluster

Peptide	Gene	Start	Entry
GIGVSLAQFYISWAE	BUB1B	146	O60566
RWVVIGDENYGEGSS	ACO2	656	Q99798
YEGTVILWDGFTGQR	COP1	491	Q8NHY2
INGSNWEGILGLAYA	BACE1	171	P56817
VTAVATQGGYGSSDW	CNTNAP3	91	Q9BZ76
GQWAIGYVSSDGSIL	CBLC	271	Q9ULV8
AQETGDNLYWGSVTG	C4B	1221	P0C0L5
GLREENEGVYNGSWG	ALDH7A1	46	P49419
YNSVSLGFALWGVLG	ALG6	166	Q9Y672
ESAYVVVGITSWGVG	ACR	251	P10323
AVDENGLWVIYATEG	ADGRL1	271	O94910
TQGTGLYDGLDWLSH	ARF5	161	P84085
QWAGGGDSDKLSYSL	FAM220BP	16	B1ANY3
AGEIAGVNWESGYLV	FGF6	66	P10767
ATEFGWTLNYGGIAL	PGD	346	P52209
IEGWNGDTGKAETYG	DSPP	106	Q9NZW4
GSKGQTAGELYQRWE	GIPR	26	P48546
GFGNIDGEYWLGLEN	ANGPTL1	341	O95841
GNASTGYGKIWLDDV	CD163L1	636	Q9NR16
DSGIWINGFDYTGIS	ERMP1	706	Q7Z2K6
IISGQEEGVYGWITA	ENTPD3	176	O75355
VGGTLGQFYQEVLWG	ITIH4	871	Q14624
HTILADYFLGVWSGG	NWD2	756	Q9ULI1
AETSDGGVYWEGIDE	PCK1	361	P35558
YIELWDVGGSVGSAS	RABL3	61	Q5HYI8
EYGGLSLWSVFGAQL	RIC1	326	Q4ADV7
AIYALGGWVGAEIGN	IPP	391	Q9Y573
TRDGVWEAYQDGTQG	NPTX1	321	Q15818
AAWCIGEYGDLLVSG	AP1G1	476	O43747
ANQVTGWLDGSAIYG	DUOX1	166	Q9NRD9
EGVTGEWARGGVQLY	OBSL1	1566	O75147
GAEIATTGQLYAAWD	BCAN	281	Q96GW7
ADLTKGYLQWVSEGG	LPIN3	696	Q9BQK8
VNWTPGGGDVDSYTV	PTPRB	926	P23467
GAAGVILWGDAGYTT	HYAL2	321	Q12891
DTVWALSYLTDGGNE	KPNA3	261	O00505
NFGEQGITVGCWDLY	LOXL3	656	P58215
GTYASEEVIWDVLSG	MAGEC1	1011	O60732
AGLYDDISTQGWFIG	CHL1	1071	O00533
WQEGLLVTFDGGYLS	LRRK1	1086	Q38SD2
YTWGDNDEGQLGDGT	HERC2	4271	O95714
QAEGAFGWITVNYGL	ENTPD8	166	Q5MY95
SLWLENVETGDAGTY	HMCN2	4356	Q8NDA2
EVGRVGYVSGWGQSD	HPR	216	P00739
QYGALGGTARSSVDW	ASL	436	P04424
KLISGGTDGAVYEWN	CFAP57	526	Q96MR6
GTDGAVYEWNLSTGK	CFAP57	531	Q96MR6
VTEDGELYTWGEGDF	HERC1	526	Q15751
DVYAWGSNSEGQLGL	HERC1	4311	Q15751
YEVEIWTGDVGGAGT	LOXHD1	816	Q8IVV2
VVGGTYSGQIVLWDN	DYNC1I1	356	O14576
SHVAGGLYSGEVLVW	DYNC2I2	231	Q96EX3
VASGITVDWAYDSGI	CPA5	376	Q8WXQ8
WVAQDAGIGAGVDSY	EDEM2	246	Q9BV94
VGAFDWSGGALLYDT	ITGAE	421	P38570
EGSILATKQEYWGNG	CD200R1L	176	Q6Q8B3
GVVIAGYTSGDVRVW	FBXW8	221	Q8N3Y1
TNVAETSDGGVYWEG	PCK2	376	Q16822
AYLALGTGVFWTLEG	KCNK17	31	Q96T54
EDGLVYEGRGWNFTG	PGLYRP1	101	O75594
FLVGQDGAIYEGVGW	PGLYRP4	276	Q96LB8
DGAIYEGVGWNVQGS	PGLYRP4	281	Q96LB8
YAWGLDSDGQLGLVG	HERC4	106	Q5GLZ8
VGDSLEVAYTGWLFQ	FKBP15	196	Q5T1M5
YGVQGWAIVQFLGDA	KDM3B	1666	Q7LBC6
DFLWGVSSSAYQIEG	LCT	906	P09848
TDDIEFYWNGGEGAV	GABRB1	186	P18505
NDIGDYVGSNLEISW	GABRD	26	O14764
SGFWYILATATDAQG	LCN10	41	Q6JVE6
VEDGVLLGAVGAYDW	ITGA11	376	Q9UKX5
LLGAVGAYDWNGAVL	ITGA11	381	Q9UKX5
SEVVGYLGGRWDVNS	MPND	291	Q8N594
AGWDQREGGQVYGTL	PSMB9	121	P28065
EEIGWLNGYNETTGE	PIK3R1	51	P27986
ARIITGQEEGAYGWI	ENTPD1	166	P49961
TALGWNYVSTLASEG	GRM8	211	O00222
GLWSAYQDGELQGSG	NPTXR	391	O95502
LWIQVELDGGTGVTY	PKD1L2	371	Q7Z442
GTAVFWYNLLRSGEG	P4HA2	481	O15460
YAGAWAVSPETELTG	ICOSLG	286	O75144
WVSFSGEIGYDLGGV	HERC5	711	Q9UII4
GSGKSNVGTWGDYDD	POTEB3	111	A0JP26
SVGNILGSLIAGYWV	SLC37A1	201	P57057
AGEINYGGRVTDDWD	DNAH1	3876	Q9P2D7
WAQGVVEAGGSFGAY	CENPB	476	P07199
SVTWYLTQDGGGSQA	CD101	181	Q93033
AGRWNYEGTALVTVG	IFT80	111	Q9P2H3
SEGTIWGQLGEDSDY	GRID2IP	841	A4D2P6
DGWLYAVGGNDGSSS	KLHL17	576	Q6TDP4
QSDEVWVGVVYGLAA	GBA2	816	Q9HCG7
GFGWAAATAAYQVEG	GBA3	6	Q9H227
LEGQDIVLYWGGSYT	CD1D	286	P15813
WRESEGSGLGYLVQV	COL20A1	46	Q9P218
AVQAGALGQGETSWY	CMYA5	3966	Q8N3K9
LSGVWVAYQEVGFSG	CRYBG2	1301	Q8N1P7
GDTQTIWARTGYLGF	DIP2C	1406	Q9Y2E4
YGNTTGSIVCGEDGW	CFHR4	431	Q92496
TLRVWGGGIYEQDEF	MANBA	386	O00462
AGNGSWTDSVAFYIL	INSRR	896	P14616
SVGAQTTAGWNYLLE	ERAP2	796	Q6P179
LWAVGSAAYQTEGGW	KL	66	Q9UEF7
AAFEYVGENIWLGGI	GLIPR1L1	91	Q6UWM5
GQWAIGYVTADGNIL	CBL	301	P22681
SGGSWVVYDGENFTG	CRYBG1	1451	Q9Y4K1
LSNTLGWGTGYAGEI	DGKE	316	P52429
GDTQTIWARTGYLGF	DIP2A	1421	Q14689
GTGLGEGYNINIAWT	HDAC9	861	Q9UKV0
DFAVIAGVSNWGGYA	DGLUCY	511	Q7Z3D6
AGRLEVFYNGAWGTV	CD163	836	Q86VB7
ANGSYRVTGDLAGWI	GALC	601	P54803
YRGSGGSFSKAQEEW	SCAMP5	176	Q8TAC9
EEWGGNGVGDDLFSY	RYR2	711	Q92736
VSGNWIEIAYGTSSG	KCTD3	381	Q9Y597
AYLWDFGDGTVSLGS	PKD1L1	621	Q8TDX9
GNWNGDRSTYGLSII	C9orf72	101	Q96LT7
AQETGDNLYWGSVTG	C4A	1221	P0C0L4
VTAVATQGGYGSSDW	CNTNAP3B	91	Q96NU0
AEGWAGNQSVVGVIY	LRRN4	616	Q8WUT4
AGEIWNGGIDECTLY	OTOGL	1876	Q3ZCN5
ELAGGSGVVYTWSLE	PKD1	1741	P98161
FLGANAVWYGAVGDS	PKD1	3291	P98161
LLASWGAGATTFQEY	MUCL3	21	Q3MIW9
NGVAGQDYWAVLSGK	MS4A12	186	Q9NXJ0
YSVATQLFIGGVTGW	FUNDC2	81	Q9BWH2
TWVGGGYINGTAEAV	SLC5A7	61	Q9GZV3
DGAISLLTYTGEGQW	SEC13	126	P55735
GTVLFNQGEEGTSWY	RAPGEF4	381	Q8WZA2
GLWTLQEGTTGVYTA	SLC35G3	176	Q8N808
GDYAWGQTGLDAIVT	RNF115	176	Q9Y4L5
DGQELDSWYVILNGT	RAPGEF6	311	Q8TEU7
VYIGSAGLDWQSLGQ	PLD5	231	Q8N7P1
ASGIVFYGELWVCAG	TLL1	16	O43897
GGLVNSLGWVLSAYA	SLC16A14	106	Q7RTX9
GTQCEYWTGGALGSE	NPHP3	226	Q7Z494
GAIGGSAYWAEEKSS	GPRASP2	416	Q96D09
KWGDAGAEYVVESTG	GAPDH	86	P04406
GGYLWTQTQATVVSG	HIF3A	311	Q9Y2N7
SYVISGDGNGKLNIW	CDC40	521	O60508
FILAVGTVAAGGYWA	SPPL2C	191	Q8IUH8
SDGLKYSLATGNWGD	POLR2B	441	P30876
IIGGTFTWTSIYGVN	SLC5A8	246	Q8N695
GGTWYGVDINNEDIA	CCT7	471	Q99832
AETGSKYVGTWVNGQ	RSPH1	131	Q8WYR4
WGYSVAVGEFDGDLN	ITGA2B	266	P08514
LSTVGSYDWAGGVFL	ITGAM	366	P11215
DVLTQYRGLSWSVGG	PLB1	416	Q6P1J6
YRGLSWSVGGDENIG	PLB1	421	Q6P1J6
SEGAAEIAGYQTLWE	SERTAD4	16	Q9NUC0
GDFGSVGATEWLEGY	TFRC	456	P02786
GWIYLGLNSSGEELN	SYT14P1	151	Q58G82
WGEGFVLVYDITDRG	RERG	76	Q96A58
YLESVDEGGVAWRAG	SHANK1	701	Q9Y566
AGAGTISEVWDYNTG	ACSL3	481	O95573
TQGTGLYEGLDWLSN	ARF4	161	P18085
LEENGKVYGNWTFGT	ATP11C	986	Q8NB49
GEYTDIQGLEWSGNF	MORN2	51	Q502X0
VLAYATVNGSLVGWD	PIK3R4	1111	Q99570
YVLGGLDWTQTFLGS	SLC45A4	211	Q5BKX6
WNTNGTLLATGSYDG	TBL1X	296	O60907
GSYDGFARIWTEDGN	TBL1X	306	O60907
YEEGWLATGNGRGVV	TULP4	41	Q9NRJ4
SYGEFGNVTRWSLGI	RNFT1	311	Q5M7Z0
IFDWGGCSDNIDYGI	WNT2	151	P09544
GGKWIVSGSEDNLVY	WDR5B	266	Q86VZ2
GTSSYQAEWILDGGS	TSR1	396	Q2NL82
GYVNWAFSEGDETGV	TRPM6	1451	Q9BX84
GSQAYEDFVAGLGWE	RALGAPA1	1831	Q6GYQ0
LGIQLAWGFYGNTVT	TCTA	51	P57738
GGLAVAGFEWNATYV	SLC5A10	86	A0PJK1
SGNTIYFGEGSWLTV	TRBJ1-3	1	A0A0J9YWP8
ALGQYTSQGGVTAWR	SLC6A13	91	Q9NSD5
FTVALGGYWSGLVEL	SPPL2A	181	Q8TCT8
ERDWTSKYGQGAGEG	TNKS1BP1	771	Q9C0C2
GSSLEETGFNWGEYL	SFMBT2	36	Q5VUG0
ETGFNWGEYLEETGA	SFMBT2	41	Q5VUG0
YDSGDEWDIGVGNLI	ZNF609	21	O15014
VGYINGTFDLVWGNG	USP47	81	Q96K76
LTSVGYAVGLGNVWR	SLC6A9	111	P48067
GANFLGEIIEWIGYA	SRD5A2	191	P31213
LQESGFYWSAVTGGE	SOCS3	41	O14543
EWDGNSQVGIGDYRI	PKHD1L1	3706	Q86WI1
YTDGANPAEWTGSVA	TGM5	246	O43548
GLWTLQEGITGVYTA	SLC35G6	176	P0C7Q6
VWSDYVGGRNGDLEE	ZG16	71	O60844
SLGYQWLSDGSGVFE	TRAP1	226	Q12931
LDSYGWLVSGGQSGL	GTF3C2	846	Q8WUA4
TGWAFLELGTSGQYN	PLBD2	96	Q8NHP8
YVVNFGAGDGANWLT	TRAPPC10	256	P48553
TGEYARLQASGAGTW	TG	1111	P01266
GLQDTGGTVNYFWGI	UIMC1	266	Q96RL1
FLGVWLVAYGVATEG	TRPM4	936	Q8TD43
TGGYNLASVSVWDLA	TLE6	351	Q9H808
WGQYATDGIGNESVK	TMEM145	226	Q8NBT3
ATGAYNGTVRIWDFG	WDR64	516	B1ANS9
GLLWISGGVTNTAQY	KLHL32	446	Q96NJ5
LYWELNQAVRTGGGS	ART5	106	Q96L15
YGSLEIQGSDPSGWE	MYO9A	1181	B2RTY4